LighthouseAI provides a centralized platform that combines software and a team of state licensing experts to manage pharmaceutical licensing and compliance across every U.S. state and jurisdiction. Its customers include manufacturers, wholesale distributors, third-party logistics providers, 503A and 503B facilities, pharmacies, repackagers, reverse distributors, virtual manufacturers, and healthcare providers. The company launched Rapid Assessments, a product that analyzes more than 100 facility attributes and produces a guaranteed set of regulatory requirements across 55 U.S. jurisdictions instantly. LighthouseAI serves 250 customers and processed 2025 change-of-ownership transactions representing more than $12 billion in combined revenue. The company reached initial profitability in Q4 2025, employs 85 people, and has recently expanded its commercial leadership with the appointment of a Chief Commercial Officer. Series A proceeds are intended to fund delivery improvements, further product development, and expanded services to support growth.

Total raised

$13M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2026